Dr. Selin Kurnaz, CEO and cofounder of Massive Bio. After emigrating from Turkey and completing a PhD at the University of Michigan, receiving multiple engineering degrees, Selin spent more than a decade specializing in delivering revenue enhancement, margin optimization and capital efficiency improvements for Healthcare and Life Science companies. Selin has written and spoken extensively about life sciences in tech and how to deliver information in creative ways. Massive Bio is an alumni of eLab and Philips Healthworks Precision Cancer Care start-up acceleration programs.

Selin joins me today to share with me her mission. It is a big one to connect cancer patients with the treatment they need through her company Massive Bio. It is an AI-driven platform connecting cancer patients and their community oncologists to bio-pharmaceutical clinical trials yielding profound improvement in access and match rates leading to faster drug development timelines and creating novel oncology data ecosystem for improved protocol design and real-world insights. Massive Bio controls patient enrollment value chain starting direct and indirect patient acquisition/identification, following with AI based pre-screening (outside the site) and resolving last mile issues such as JIT site activation, patient referrals and resolution of insurance related matters.

“As long as you have the right team that believes in you as long as you have the customers that you can deliver to everything else is just a story….and don’t listen” - Selin Kurnaz

Today on When She Founded:

• We learn about Selin’s company Massive Bio and how they help cancer patients
• Selin shares her background growing up in Turkey and her studies in engineering in the US
• How her talents in analysis shaped her career
• How a family member’s cancer changed the trajectory of her career
• The challenges of starting a new company and how to maneuver around them
• How she did her due diligence prior to leaving her career to pursue Massive Bio
• How the model for her company changed and evolved from the beginning
• She explains more about the Virtual Tumor Board and how it was scaled up
• She shares the importance of learning and adapting your product and model for the business
• Selin tells the story of the name of her company - Massive Bio
• We learn about Massive Bio’s stakeholders and their personal attachment to cancer
• She explains the capital investments in her business and her philosophy about when to accept that capital
• COVID-19 has impacted Selin’s company and the patient’s mobility and the forward looking of the FDA
• The adversity that Selin has faced and how she overcame it with passion and perseverance

Connect with Selin Kurnaz:  https://massivebio.com

Subscribe, Rate & Share Your Favorite Episodes!

Thanks for tuning into today’s episode of When She Founded with your host, Somer Hamrick. If you enjoyed this episode, please head over to Apple Podcasts to subscribe and leave a rating and review.

Don’t forget to visit our website, connect with Somer on LinkedIn, and share your favorite episodes across social media.